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Introduction
Cardiac surgery-associated acute kidney injury (CSA-
AKI) is a common postoperative complication, despite
advances in surgical techniques and intensive care, mor-
tality and morbidity associated with acute renal failure
have not markedly changed in the last decade. Depend-
ing on the definition used, the incidence of CSA-AKI is
reported to range from 1 to 30%. CSA-AKI requiring
continuous renal replacement therapy (CRRT) occurs in
1.2-3.0% of cardiac surgery cohorts and is independently
associated with mortality.
Objectives
We studied mortality differences between CRRT and
nonCRRT patients. We studied Timing effect (Early vs
Late CRRT initiation respect to ICU admission) using
non-CRRT as control group.
Methods
We performed an observational prospective cohort
study of 2100 patients undergoing different types of
cardiac surgery, from 2006 to 2011 in a tertiary univer-
sity hospital. Of these, 87 patients developed AKIN 2-3
stage within the first 24h of immediate postsurgical
ICU admission, whereas 30 patients received CRRT
during their ICU stay. All those patients with CKD 4-5
were excluded. Severity of AKI was defined by AKIN
score (urine output (UO) and serum creatinine). We
classified patients in early group ( < 48 hours) and late
group (>48 hours) based on time from ICU admission
to CRRT.
Results
Baseline patients characteristics were: Mean age (years)
65 ± 10; APACHE II 20 ± 8; SOFA 10 ± 3; UO (ml) 6h
before CRRT 161 ± 225; Creatinine at CRRT initiation
(umol/L) 298,20 ± 98. Mortality at 90 days in patients
with AKIN 2-3 the first 24h of ICU admission was
37,9%. The mortality in patients with AKIN 2-3 that
required CRRT was 63,3%, compared with 24,6% in
patients that did not require CRRT. Timing analysis was
performed (Early vs Late) using non CRRT as control
group: Mean age in years (60 ± 8 vs 70 ± 7) vs 66 ± 10;
SOFA (11 ± 3 vs 11 ± 3) vs 10 ± 3; APACHE (22 ± 6 vs
23 ± 7) vs 19 ± 8; Creatinine at ICU admission (umol/L)
(55 ± 14 vs 66 ± 17) vs 59 ± 8; UO 24h at ICU admission
(ml/k/h) (0,3 ± 0,2 vs 0,7 ± 0,5) vs 0,8 ± 0,4; Urine output
6h previous to CRRT (0,2 ± 0,2 vs 0,5 ± 0,6)*. *p < 0,05.
Conclusions
Higher mortality in those AKIN 2-3 whom needed
CRRT vs non-CRRT (63.3% vs 24.6%). Timing analysis
revealed no survival differences between those patients
who were early initiated on CRRT ( < 48 h respect to
ICU admission) and those who were initiated later
(60.0% VS 66.7%). Urine output 6h previous to CRRT
was significative higher in the late group respect to the
early group (0.54 ml/kg/h vs 0.18 ml/gh/h) introducing
some concerns about CRRT indication on this Late
group. CRRT initiation in advanced AKIN patients
(AKIN 2-3) who still present preserved UO > 0.5 ml/k/h
should be discouraged, these patients present higher
mortality compared to non-CRRT patients.
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